Accession Number: | 0001209191-22-042310 |
Date: | 2022-07-15 |
Issuer: | ACELRX PHARMACEUTICALS INC (ACRX) |
Original Submission Date: |
BOZILENKO MARINA
C/O ACELRX PHARMACEUTICALS, INC.
25821 INDUSTRIAL BLVD., SUITE 400
HAYWARD, CA 94545
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-07-15 | A | 15,500 | a | $0.00 | 40,500 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.2309 | 2022-07-15 | deemed execution date | A | 31,000 (a) | 2022-07-15 | 2032-07-14 | common stock 31,000 | $0.23 | 31,000 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
f2 | 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to reporting person's continuous service to the company. |
f3 | 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to reporting person's continuous service to the company. |